The combination of TKIs with CX-4945 demonstrates the synergistic efficacy through restoring IKAROS transcriptional repression of GLUT1 and further suppressing glycolysis in Ph+ ALL. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.